EDGAR Filing Documents for 0001493152-22-023033

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001493152-22-023033

Filing Date

2022-08-15

Accepted

2022-08-15 18:00:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		form-s3.htm	S-3	587109
2		ex1-2.htm	EX-1.2	282787
3		ex4-3.htm	EX-4.3	446174
4		ex4-4.htm	EX-4.4	450689
5		ex5-1.htm	EX-5.1	28066
6		ex5-2.htm	EX-5.2	16127
7		ex23-1.htm	EX-23.1	3254
8		ex107.htm	EX-FILING FEES	187878
9		form-s3_001.jpg	GRAPHIC	18218
10		form-s3_002.jpg	GRAPHIC	13650
11		form-s3_003.jpg	GRAPHIC	17240
12		ex5-1_001.jpg	GRAPHIC	2606
13		ex5-2_001.jpg	GRAPHIC	2606
	Complete submission text file	0001493152-22-023033.txt		2078466

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451

Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400

Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)